In this episode of the Oncology Brothers podcast, we dived deep into the complexities of treating multiple myeloma, focusing on two challenging cases from the community. Joined by experts Marco Davila, MD PhD, from Roswell Park Comprehensive Cancer Center and Krina Patel, MD MSc, from MD Anderson Cancer Center, they discuss the nuances of treatment options for patients experiencing disease relapse post-transplant and disease progression while on maintenance therapy.

Key topics included:

The importance of thorough workup and repeat cytogenetics in high-risk multiple myeloma patients
The debate between CAR T-cell therapy and bispecific antibodies as treatment options
Strategies for managing patients with comorbidities and the role of shared decision-making in treatment planning
Insights into the side effects associated with CAR-T and bispecific therapies, including infection risks and neurological symptoms

Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o

Follow us on social media:

X/Twitter: https://x.com/oncbrothers
Instagram: https://www.instagram.com/oncbrothers
Website: https://oncbrothers.com/

Join us as we explored the latest advancements in multiple myeloma treatment and the exciting potential for achieving long-term remission and even cure in select patient populations.

Don't forget to like, subscribe, and hit the notification bell for more insightful discussions on oncology!

#MultipleMyeloma, #CARTtherapy, #BispecificAntibody, #RelapsedMyeloma, #OncologyBrothers

Challenging Cases in Relapsed/Refractory Multiple Myeloma - Drs. Marco Davila & Krina Patel

Oncology Brothers: Practice-Changing Cancer Discussions

Challenging Cases in Relapsed/Refractory Multiple Myeloma - Drs. Marco Davila & Krina Patel